Your region is set to . If this is incorrect, please change your region.

Anthony G. Creber
Partner, Patent & Trademark Agent

Speaks: English, French

Year of Call: 1981 - Ontario

Primary Office: Ottawa

Anthony G. Creber

Tony Creber is a senior partner in Gowling WLG's Ottawa office and past Canadian leader of Gowling WLG's Intellectual Property Litigation & Strategy Group.

Tony has been an IP litigator for over 35 years and is recognized as one of the leading IP litigators in Canada. Tony’s primary focus is on chemical and pharmaceutical patent litigation, including major patent infringement cases. His practice also includes trade-mark litigation, regulatory issues and advising on strategic IP life cycle matters.

He has appeared extensively in the Federal Court (both Trial and Appeal) and the Supreme Court of Canada on patent matters, including questions of patentability of life forms, patent licensing and the infringement of biotech patents. 

His recent Supreme Court appearances include leading cases that have defined key aspects of Canadian patent law such as Monsanto v. Schmeiser  and Apotex v. Sanofi-Synthelabo (“Plavix”).

Generally, Tony appears for patentees and represents many major pharmaceutical companies, including Eli Lilly, BMS, Novartis, Hoffmann-La Roche, Purdue, Allergan and Sanofi.

As the lead partner in the Apotex v. Sanofi-Synthelabo Canada case, Anthony won the coveted “Milestone Case of the Year 2014” and "Patent Case of the Year 2009" awards given by Managing Intellectual Property. Tony also received Managing Intellectual Property’s “IP Practitioner of the Year 2014” award.

During the past 20 years, Tony has consistently been recognized as a one of the pre-eminent intellectual property law practitioners and litigators in Canada by numerous publications. 

Chambers Global 2014 describes him as “the go-to person for patent litigation matters in the pharmaceutical and chemical sectors”; Benchmark Canada 2014 refers to him as a “litigation star”; Who’s Who Legal Canada 2014 calls him “a leader in the field of patent litigation.” He is also listed as a top lawyer in Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada and The Best Lawyers in Canada.

He is also a registered patent and trademark agent and is permitted to practice before the U.S. Patent and Trademark Office as a patent agent.


"The go-to person for patent litigation matters in the pharmaceutical and chemical sectors."
Chambers Global 2014

Featured client work

Federal Court awards Eli Lilly $106 million in patent damages

ClientWork January 23, 2015

Featured insights & resources

Memberships

Career & Recognition

2016

November 2016

2016

2016

October 2016

2016

2016

May 2016

2016

April 2016

2015

December 2015

Lexpert/ROB Special Edition on Canada’s Leading Litigation Lawyers

2015

December 2015

Who’s Who Legal: Canada 2015

2015

November 2015

Chambers Canada 2016

2015

October 2015

LMG Life Sciences 2015

2015

September 2015

The Best Lawyers in Canada 2016

2015

September 2015

The International Who’s Who of Business Lawyers 2015

2015

August 2015

Expert Guides: Patents

2015

July 2015

IAM Patent 1000, 2015

2015

July 2015

Canadian Legal Lexpert Directory 2015

2015

July 2015

Who’s Who Legal: Patents 2015

2015

July 2015

Managing Intellectual Property 2015

2015

May 2015

Who’s Who Legal: Life Sciences 2015

2015

April 2015

Benchmark Canada: The Definitive Guide to Canada’s Leading Litigation Firms & Attorneys 2015

2015

April 2015

Chambers Global 2015

2015

February 2015

The Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada 2015

2014

December 2014

Lexpert recognizes Gowlings professionals as leading litigation lawyers

2014

November 2014

LMG Life Sciences 2014

2014

October 2014

Who's Who Legal: Canada 2014

2014

October 2014

LMG Life Sciences Awards 2014

2014

September 2014

Managing IP's IP Stars Handbook 2014

2014

September 2014

Who’s Who Legal: The International Who’s Who of Business Lawyers 2014

2014

September 2014

The Best Lawyers in Canada 2015

2014

July 2014

IAM Patent 1000, 2014

2014

July 2014

Canadian Legal Lexpert Directory 2014

2014

July 2014

Who's Who Legal – The International Who's Who of Patent Lawyers 2014

2014

April 2014

Benchmark Canada: The Definitive Guide to Canada’s Leading Litigation Firms & Attorneys 2014

2014

April 2014

Chambers Global 2014

2014

April 2014

Gowlings wins big at the Managing IP North America Awards

2014

April 2014

Who's Who Legal: The International Who's Who of Life Sciences Lawyers 2014

2014

February 2014

Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada 2014

2014

2014

Managing Intellectual Property: Practitioner of the Year - Canada

2014

2014

Managing Intellectual Property - Milestone Case

2014

2014

MIP - Milestone Case

2013

December 2013

Lexpert 2013 Guide to the Leading US/Canada Cross-border Litigation Lawyers in Canada

2013

November 2013

Who's Who Legal: Canada 2013

2013

September 2013

The Best Lawyers in Canada 2014

2013

September 2013

Who’s Who Legal – The International Who’s Who of Patent Lawyers 2013

2013

August 2013

LMG Life Sciences 2013

2013

July 2013

Canadian Legal Lexpert Directory 2013

2013

July 2013

Who’s Who Legal: The International Who’s Who of Business Lawyers 2013

2013

June 2013

IAM Patent 1000 , 2013

2013

April 2013

Chambers Global 2013

2013

March 2013

Benchmark Canada 2013

2013

February 2013

The Best Lawyers in Canada® 2013

2013

February 2013

2013 Lexpert®/American Lawyer Guide to the Leading 500 Lawyers in Canada

2012

December 2012

2012 Lexpert® Guide to the Leading U.S./Canada Cross-Border Litigation Lawyers

2012

December 2012

Who's Who Legal: Canada 2012

2012

July 2012

Canadian Legal Lexpert Directory 2012

2012

July 2012

Who’s Who Legal: The International Who’s Who of Business Lawyers 2012

2012

July 2012

IAM Patent 1000 , 2012

2012

June 2012

PLC Which Lawyer? 2012

2012

April 2012

Benchmark Canada 2012

2012

April 2012

Chambers Global 2012

2012

February 2012

Lexpert®/American Lawyer Guide to the Leading 500 Lawyers in Canada 2012

2012

February 2012

The Best Lawyers in Canada 2012

2011

December 2011

Who’s Who Legal 2011

2011

May 2011

Who’s Who Legal - The International Who’s Who of Business Lawyers , 2011

2011

May 2011

Lexpert/ American Lawyer Guide to the Leading 500 Lawyers in Canada , 2011

2011

March 2011

PLC Which Lawyer? 2011

2011

February 2011

The Best Lawyers in Canada® 2011

2011

February 2011

Lexpert® 2011 Guide to the Leading US/Canada Cross-Border Litigation Lawyers in Canada

2011

February 2011

Canadian Legal Lexpert Directory , 2011

2010

February 2010

Expert Guides, 2010

2010

February 2010

Lexpert American Lawyer Guide to the Leading 500 Lawyers in Canada , 2010

2010

February 2010

Canadian Legal Lexpert Directory , 2010

2010

February 2010

PLC Which Lawyer? Yearbook , 2010

2010

February 2010

The Best Lawyers in Canada® 2010

2009

2009

MIP: Case of the Year - Canada Patent

1981

May 1981

Gowling & Henderson

1981

1981

Year of Call, Ontario

1979

1979

University of Toronto, LLB

1976

1976

Queen's University, BSc (Honours, Chemistry)

Anthony Creber
Profile highlights

#
Anthony Creber

Tony Creber is a senior partner in Gowling WLG's Ottawa office and past Canadian...

Memberships

Anthony Creber
Profile highlights

#
Anthony Creber

Tony Creber is a senior partner in Gowling WLG's Ottawa office and past Canadian...

Insights & Resources

Client Work

Federal Court affirms principle of claim differentiation in evaluating utility

Client Work June 19, 2015

Federal Court awards Eli Lilly $106 million in patent damages

Client Work January 23, 2015

Tony has litigated hundreds of patent-related cases, many of which involve multiple patents, multiple defendants and multiple court files. These cases include matters related to the following drugs:

  • Aclasta®
  • Adderall®
  • Alertec®
  • Alimta®
  • Altace®
  • Avalide®
  • Avapro®
  • Axid®
  • Boniva®
  • Capoten®
  • Ceclor®
  • Cellcept®
  • Claritin®
  • Diflun®
  • Dobutrex®
  • Effexor®
  • Evista®
  • Exelon®
  • Exjade®
  • Floxin®
  • Gleevec®
  • Hismanal®
  • Kefzol®
  • Lamisil®
  • Levaquin®
  • Maxipime®
  • Monopril®
  • Motilium®
  • Myfortic®
  • Neoral®
  • Nizoral®
  • Oxycontin®
  • Paxil®
  • Plavix®
  • Pravachol®
  • Prepulsid®
  • Prozac®
  • Rocephin®
  • Sandimmune®
  • Serzone®
  • Strattera®
  • Tarceva®
  • Targin®
  • Taxotere®
  • Tequin®
  • TobiPodhaler®
  • Tolectin®
  • Tracleer®
  • Trifexis®
  • Urso®
  • Valcyte®
  • Vancocin®
  • Vesicare®
  • Xeloda®
  • Zithromax®
  • Zometa®
  • Zoloft®
  • Zyprexa®

Anthony Creber
Profile highlights

#
Anthony Creber

Tony Creber is a senior partner in Gowling WLG's Ottawa office and past Canadian...

Find similar people

Government Affairs

Government Affairs

Intellectual Property

Intellectual Property

IP Litigation & Strategy

IP Litigation & Strategy

Patents

Patents

Life Sciences

Life Sciences

Manufacturing

Manufacturing

Tech

Tech